Gene · 407031
Papers2,938
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,938
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis. | Transl Oncol | 2026 | 41547146 | PubTator, text mining | PubMed |
| [Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer. | Oncol Rep | 2026 | 41456436 | PubTator, text mining | PubMed |
| Interplay between RNA-protein interactions and RNA structures in gene regulation. | FEBS Open Bio | 2026 | 40936360 | PubTator, text mining | PubMed |
| Gamma-retrovirus design for efficacious microRNA-mediated gene knock-down and protein co-expression without compromising titers. | NAR Mol Med | 2025 | 41426227 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| Regulatory effects of miR-30c knockout on hepatic lipid metabolism and progression of liver fibrosis. | BMC Gastroenterol | 2025 | 41174509 | PubTator, text mining | PubMed |
| Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers. | BMC Cancer | 2025 | 41168704 | PubTator, text mining | PubMed |
| MicroRNA Deregulation and Immune Checkpoint Interactions in Common Variable Immunodeficiency and CLL-Associated Secondary Immunodeficiency. | Cells | 2025 | 41148792 | PubTator, text mining | PubMed |
| Exosome miRNA sorting controlled by RNA-binding protein-motif interactions. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132505 | PubTator, text mining | PubMed |
| Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers. | Mol Cancer | 2025 | 41063167 | PubTator, text mining | PubMed |
| Diagnostic and prognostic potential of microRNA profiles in endometrioid endometrial cancer. | Sci Rep | 2025 | 41053314 | PubTator, text mining | PubMed |
| Omics characteristics and epigenetic modifications of adipose-derived stem cells. | J Biol Chem | 2025 | 41005477 | PubTator, text mining | PubMed |
| Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions. | Int J Nanomedicine | 2025 | 40933023 | PubTator, text mining | PubMed |
| Gut Microbiota-Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers. | FASEB J | 2025 | 40899744 | PubTator, text mining | PubMed |
| Near-Infrared-Responsive Digital PCR-Assisted Renal Cancer Exosomal miRNAs Insights and Regulation of Macrophage Polarization. | Adv Sci (Weinh) | 2025 | 40883643 | PubTator, text mining | PubMed |
| A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence. | Cells | 2025 | 40862758 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis. | J Cancer Res Clin Oncol | 2025 | 40844552 | PubTator, text mining | PubMed |
| miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infection. | Sci Rep | 2025 | 40841549 | PubTator, text mining | PubMed |
| Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma. | RNA Biol | 2025 | 40836845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407031/papers?page=2